WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.
更新时间：2025-07-11 直达：westvacpharma.com
暂无描述...
暂无描述...
阳光财经致力于为用户提供全面的财经资讯，包括金融咨询、投资理财等多方面内容，助您把握投资先机，智慧理财。
专注高端科研测试仪器预约和相关技术服务，为全球科学家和工程师提升研发效率
魔秘法略专注提供全网深度游戏攻略，覆盖《原神》《崩坏：星穹铁道》《艾尔登法环》等800+款游戏的速通路线图、隐藏成就解锁、MOD开发教程及免加密补丁下载。每日同步Steam/Epic/PSN平台最新资讯，独创「卡关急救系统」3分钟定位解决方案！
苏州昆承工业设备有限公司是专业的物流包装解决方案服务商，公司主要产品线有：厚片/薄片吸塑制品、压铸/注塑/吹塑/吸塑围板箱、注塑周转箱、注塑托盘、防护内衬、纸箱、木托、金属料架等系列产品。
明核仪器（苏州）有限公司主营产品有辐射剂量报警仪、氡气检测仪、辐射测量仪、测氡仪、核辐射监测等。公司为客户降低采购成本和风险，为客户投资提供切实保障。欢迎新老顾客来电垂询。
山东天利源新型材料有限公司主营高分子合成材料及蜂窝板和周转箱等制品的生产、销售。拥有环保印刷可循环利用高分子合成材料全部的专利、商标等知识产权所有权，目前拥有专利10项，其中6